Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
opioid |
| gptkbp:CASNumber |
2784-73-8
|
| gptkbp:chemicalFormula |
C19H21NO4
|
| gptkbp:contains_functional_group |
acetyl group
morphinan skeleton |
| https://www.w3.org/2000/01/rdf-schema#label |
6-AM
|
| gptkbp:is_a_biomarker_for |
heroin use
|
| gptkbp:is_a_metabolite_in |
human body
|
| gptkbp:is_a_semi-synthetic_derivative_of |
gptkb:morphine
|
| gptkbp:IUPACName |
gptkb:6-acetylmorphine
|
| gptkbp:legalStatus |
gptkb:Schedule_I_(US)
|
| gptkbp:metabolite_of |
gptkb:morphine
amphetamine |
| gptkbp:molecularWeight |
327.37 g/mol
|
| gptkbp:otherName |
gptkb:6-monoacetylmorphine
6-monoacetylmorphine (6-MAM) |
| gptkbp:parent_compound |
gptkb:morphine
|
| gptkbp:psychoactive |
euphoria
analgesia |
| gptkbp:PubChem_CID |
gptkb:CHEMBL1201202
5362440 CHEBI:140570 |
| gptkbp:routeOfAdministration |
smoking
intravenous intranasal |
| gptkbp:UNII |
Q1J8A4K29B
|
| gptkbp:bfsParent |
gptkb:6-monoacetylmorphine
|
| gptkbp:bfsLayer |
7
|